Working… Menu

A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01396213
Recruitment Status : Completed
First Posted : July 18, 2011
Last Update Posted : September 20, 2017
Teva Pharmaceuticals USA
Information provided by (Responsible Party):
9 Meters Biopharma, Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : August 20, 2013
Actual Study Completion Date : August 20, 2013
Certification/Extension First Submitted : September 11, 2017